Evidence map›Paper›PMID 8774911›Full record

ArticleNucleic acids research1996

Methylation inhibitors can increase the rate of cytosine deamination by (cytosine-5)-DNA methyltransferase.

J M Zingg, J C Shen, A S Yang, H Rapoport, P A Jones

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Nucleic acids research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. A convergent synthesis of carbocyclic sinefungin and its C5 epimer.European journal of organic chemistry · 2014
    Article
  7. Article
  8. Article
  9. Active DNA demethylation: many roads lead to Rome.Nature reviews. Molecular cell biology · 2010
    Review
  10. Review
  11. Article
  12. Article
  13. An unexpectedly high excision capacity for mispaired 5-hydroxymethyluracil in human cell extracts.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  14. Article
  15. DNA methylation as a target for drug design.Pharmaceutical research · 1998
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J M ZinggDepartment of Biochemistry and Molecular Biology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles 90033, USA.
J C Shen
A S Yang
H Rapoport
P A Jones
USC Norris Comprehensive Cancer Center · US

Funding

DNA METHYLATION IN DEVELOPMENT AND CANCERR35CA049758 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JONES, PETER A · 1989 to 2000
$121k
NCI NIH HHS R35 CA49758
6 · The paper itself

Abstract

The target cytosines of (cytosine-5)-DNA methyltransferases in prokaryotic and eukaryotic DNA show increased rates of C-->T transition mutations compared to non-target cytosines. These mutations are induced either by the spontaneous deamination of 5-mC-->T generating inefficiently repaired G:T rather than G:U mismatches, or by the enzyme-induced C-->U deamination which occurs under conditions of reduced levels of S-adenosylmethionine (AdoMet) and S-adenosylhomocysteine (AdoHcy). We tested whether various inhibitors of (cytosine-5)-DNA methyltransferases analogous to AdoMet and AdoHcy would affect the rate of enzyme-induced deamination of the target cytosine by M.HpaII and M.SssI. Interestingly, we found two compounds, sinefungin and 5'-amino-5'-deoxyadenosine, that increased the rate of deamination 10(3)-fold in the presence and 10(4)-fold in the absence of AdoMet and AdoHcy. We have therefore identified the first mutagenic compounds specific for the target sites of (cytosine-5)-DNA methyltransferases. A number of analogs of AdoMet and AdoHcy have been considered as possible antiviral, anticancer, antifungal and antiparasitic agents. Our findings show that chemotherapeutic agents with affinities to the cofactor binding pocket of (cytosine-5)-DNA methyltransferase should be tested for their potential mutagenic effects.

Indexed as

BacteriaBinding, CompetitiveDeaminationDNADNA-Cytosine MethylasesDose-Response Relationship, DrugEnzyme InhibitorsMethylationProtein BindingS-AdenosylhomocysteineS-AdenosylmethionineStructure-Activity RelationshipDNADNA-Cytosine MethylasesDNA modification methylase HpaIIDNA modification methylase SssIEnzyme InhibitorsS-AdenosylhomocysteineS-Adenosylmethionine

Identifiers

PMID8774911
PMCPMC146075
OpenAlexW2056031143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.